FDA Approves Toujeo (insulin glargine) Max SoloStar

BRIDGEWATER, N.J., March 27, 2018 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) approved Sanofi ' s Toujeo (insulin glargine 300 Units/mL) Max SoloStar, the highest capacity long-acting insulin pen that will be available on the...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news